In spondyloarthritis (SpA), tumor necrosis factor (TNF)-α antagonists are rarely linked to systemic lupus erythematosus (SLE). Usually in such cases, the biological agent is discontinued.
A 30-year-old woman with Crohn-related SpA presented with facial rash after treatment with a third dose of infliximab (IFX). She had been diagnosed with Crohn disease 3 years earlier based …